Death rate for all cancers down in U.S. from 2000 to 2009

This article originally appeared here.
Share this content:
Death Rate for All Cancers Down in U.S. From 2000 to 2009
Death Rate for All Cancers Down in U.S. From 2000 to 2009

(HealthDay News) -- From 2000 to 2009, there was a general decrease in the death rates for all cancers combined for men and women, although the incidence of some cancers continued to rise, according to a report published online Jan. 7 in the Journal of the National Cancer Institute.

Ahmedin Jemal, D.V.M., Ph.D., from the American Cancer Society in Atlanta, and colleagues used data from the National Cancer Institute, the U.S. Centers for Disease Control and Prevention, and the North American Association of Central Cancer Registries to assess cancer incidence, and used CDC data to assess death rates and trends. Long-term (1975/1992 to 2009) and short-term (2000 to 2009) trends in incidence and death rates for all cancers combined and for the leading cancers were examined.

The researchers found that, for men and women of all major racial and ethnic groups, for all cancers combined and for most major cancers, the death rates continued to decline, with a 1.5 percent annual decrease in the rates from 2000 to 2009 for both sexes combined. The overall incidence rates stabilized for women and decreased for men. The incidence of some cancers (e.g., liver, kidney, and thyroid) increased.

"Although substantial progress in cancer prevention and control has been made for many cancers, including lung, colorectal, female breast, and prostate cancers, incidence and/or death rates continue to increase for some cancer sites (e.g., liver, pancreas, kidney, thyroid, and melanoma), underscoring the need for additional etiologic research for the identification of major risk factors and the development of appropriate interventions," the authors write.

Full Text

You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs